Keywords: bayer, ends, mmpi, trials, cancer, arthritis, called

Bayer ends MMPI trials in cancer, arthritis

Article | 27 September 1999

Print This

Bayer has called a halt to all its clinical trials of BAY 12-9566, amatrix metalloproteinase inhibitor, after disappointing results in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in